Furney Natalie Anne Marie
Global General Counsel
Furney Natalie Anne Marie has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 13, 2026.
On the most recent filing, Furney Natalie Anne Marie is listed as Global General Counsel at TAKEDA PHARMACEUTICAL CO LTD. Inside the rolling window, Furney Natalie Anne Marie reported no open-market purchases and 1 open-market sale totaling $528K in TAK.
Companies traded
Other insiders at TAK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$528K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Furney Natalie Anne Marie made?
Furney Natalie Anne Marie has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Furney Natalie Anne Marie trade?
Furney Natalie Anne Marie has filed SEC Form 4 disclosures for 1 company, including TAK.
When was Furney Natalie Anne Marie's most recent SEC Form 4 filing?
Furney Natalie Anne Marie's most recent SEC Form 4 filing on Tracefour is dated Aug 13, 2026.
What is Furney Natalie Anne Marie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Furney Natalie Anne Marie is listed as Global General Counsel.
What is Furney Natalie Anne Marie's total buy and sell value in the current window?
Inside the rolling retention window, Furney Natalie Anne Marie bought $0 and sold $528K based on SEC Form 4 filings.
What was Furney Natalie Anne Marie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,868 TAK shares on 2026-08-10, worth $528K, per SEC Form 4 filings.